Related references
Note: Only part of the references are listed.Pharmacological potential of ginseng and its major component ginsenosides
Zubair Ahmed Ratan et al.
JOURNAL OF GINSENG RESEARCH (2021)
Elucidation of S-Allylcysteine Role in Inducing Apoptosis by Inhibiting PD-L1 Expression in Human Lung Cancer Cells
Fahad Khan et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)
The Anticancer Potential of Apigenin Via Immunoregulation
Lu Xu et al.
CURRENT PHARMACEUTICAL DESIGN (2021)
NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical Outcomes
Anju Singh et al.
CLINICAL CANCER RESEARCH (2021)
Triptolide suppresses oral cancer cell PD-L1 expression in the interferon-γ-modulated microenvironment in vitro, in vivo, and in clinical patients
Chin-Shan Kuo et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Pembrolizumab for advanced cervical cancer: safety and efficacy
Francesca De Felice et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2021)
The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm
Quentin Lecocq et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Licochalcone A inhibits proliferation and promotes apoptosis of colon cancer cell by targeting programmed cell death-ligand 1 via the NF-KB and Ras/Raf/MEK pathways
Xueshuang Liu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Lignans of Sesame (Sesamum indicum L.): A Comprehensive Review
Mebeaselassie Andargie et al.
MOLECULES (2021)
Recent Advancements on Immunomodulatory Mechanisms of Resveratrol in Tumor Microenvironment
Gagan Chhabra et al.
MOLECULES (2021)
Characterizing the molecular regulation of inhibitory immune checkpoints with multimodal single-cell screens
Efthymia Papalexi et al.
NATURE GENETICS (2021)
Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-KB/STAT3 and NF-KB/CSN5 signaling pathways
Zhiyan Ruan et al.
PANCREATOLOGY (2021)
TIGIT/CD226 Axis Regulates Anti-Tumor Immunity
Jinah Yeo et al.
PHARMACEUTICALS (2021)
Inhibition of T-cell-mediated immune response via the PD-1/PD-L1 axis in cholangiocarcinoma cells
Tawit Suriyo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Usnic acid suppresses cervical cancer cell proliferation by inhibiting PD-L1 expression and enhancing T-lymphocyte tumor-killing activity
Tong Xin Sun et al.
PHYTOTHERAPY RESEARCH (2021)
Banxia Xiexin Decoction Inhibits the Expression of PD-L1 Through Multi-Target and Multi-Pathway Regulation of Major Oncogenes in Gastric Cancer
Xuan Feng et al.
ONCOTARGETS AND THERAPY (2021)
Clinical Insights Into Novel Immune Checkpoint Inhibitors
Jii Bum Lee et al.
FRONTIERS IN PHARMACOLOGY (2021)
Antitumor Effects of Ursolic Acid through Mediating the Inhibition of STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer Cells
Dong Young Kang et al.
BIOMEDICINES (2021)
Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer
Ze-Bo Jiang et al.
CANCER LETTERS (2021)
Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity
Ao Yang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Hao Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Natural Compounds as Metabolic Modulators of the Tumor Microenvironment
Ana S. Dias et al.
MOLECULES (2021)
TIGIT-Fc Promotes Antitumor Immunity
Xian Shen et al.
CANCER IMMUNOLOGY RESEARCH (2021)
TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer
Zhouhong Ge et al.
FRONTIERS IN IMMUNOLOGY (2021)
Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells
Alexis Rugamba et al.
CELLS (2021)
VISTA: A Promising Target for Cancer Immunotherapy?
Marco Tagliamento et al.
IMMUNOTARGETS AND THERAPY (2021)
PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity
Haiping Jiang et al.
ONCOIMMUNOLOGY (2021)
Immune-modulating Effect of Korean Red Ginseng by Balancing the Ratio of Peripheral T Lymphocytes in Bile Duct or Pancreatic Cancer Patients With Adjuvant Chemotherapy
Im-Kyung Kim et al.
IN VIVO (2021)
Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers
Samaneh Brenjian et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2020)
Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity
Sara Verdura et al.
AGING-US (2020)
A Review: The Anti-inflammatory, Anticancer and Antibacterial Properties of Four Kinds of Licorice Flavonoids Isolated from Licorice
Ze-Feng Wang et al.
CURRENT MEDICINAL CHEMISTRY (2020)
VISTA: Coming of age as a multi-lineage immune checkpoint
M. A. ElTanbouly et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Molecular mechanisms of action of hesperidin in cancer: Recent trends and advancements
Vaishali Aggarwal et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2020)
Inhibitory Effect of Hesperidin on the Expression of Programmed Death Ligand (PD-L1) in Breast Cancer
Prachya Kongtawelert et al.
MOLECULES (2020)
β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT
Yufei Liang et al.
ACTA HISTOCHEMICA (2020)
Evaluation of anti-cancer potency of silibinin on murine renal carcinoma RenCa cells in an animal model with an intact immune system
Chao Yang et al.
ANTI-CANCER DRUGS (2020)
Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer
Xuqian Deng et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab-Response
Omid Hamid et al.
CLINICAL CANCER RESEARCH (2020)
FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1, Enhances T-Cell Activation Resulting in Potent Antitumor Activity
Matthew Kraman et al.
CLINICAL CANCER RESEARCH (2020)
Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
Chaohe Zhang et al.
FRONTIERS IN PHARMACOLOGY (2020)
The TLR4/ERK/PD-L1 axis may contribute to NSCLC initiation
Xiuhua Kang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
(-)-Sativan Inhibits Tumor Development and Regulates miR-200c/PD-L1 in Triple Negative Breast Cancer Cells
Fu Peng et al.
FRONTIERS IN PHARMACOLOGY (2020)
Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity
Dominique Delmas et al.
MOLECULES (2020)
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
Raju K. Vaddepally et al.
CANCERS (2020)
NFE2L2/KEAP1 Mutations Correlate with Higher Tumor Mutational Burden Value/PD-L1 Expression and Potentiate Improved Clinical Outcome with Immunotherapy
Xian Xu et al.
ONCOLOGIST (2020)
Panaxadiol inhibits programmed cell death-ligand 1 expression and tumour proliferation via hypoxia-inducible factor (HIF)-1 alpha and STAT3 in human colon cancer cells
Zhe Wang et al.
PHARMACOLOGICAL RESEARCH (2020)
Microenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors
Makiko Hayashi et al.
CANCER RESEARCH (2020)
Immunotherapies and Combination Strategies for Immuno-Oncology
Cody Barbari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5
Yang Liu et al.
ACTA PHARMACEUTICA SINICA B (2020)
Lycopene as a Natural Antioxidant Used to Prevent Human Health Disorders
Muhammad Imran et al.
ANTIOXIDANTS (2020)
Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer
Hong Xiang Zuo et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy
Xing Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Natural products and their derivatives: Promising modulators of tumor immunotherapy
Li-Juan Deng et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism
Leila Sarah Sellam et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)
Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3
Taeko Hayakawa et al.
CANCER SCIENCE (2020)
The tumor microenvironment
Nicole M. Anderson et al.
CURRENT BIOLOGY (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Inhibition of programmed death ligand 1 (PD-L1) expression in breast cancer cells by sesamin
Prachya Kongtawelert et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Polydatin executes anticancer effects against glioblastoma multiforme by inhibiting the EGFR-AKT/ERK1/2/STAT3-SOX2/Snail signaling pathway
Yaodong Chen et al.
LIFE SCIENCES (2020)
Targeting STAT3 in Cancer Immunotherapy
Sailan Zou et al.
MOLECULAR CANCER (2020)
ICOS+Tregs: A Functional Subset of Tregs in Immune Diseases
Dan-Yang Li et al.
FRONTIERS IN IMMUNOLOGY (2020)
TIGIT in cancer immunotherapy
Joe-Marc Chauvin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Synergistic anti-liver cancer effects of curcumin and total ginsenosides
Zhe Deng et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells
Dong Li et al.
ONCOLOGY RESEARCH (2020)
Regulation of PD-L1 Expression by NF-κB in Cancer
Fabrizio Antonangeli et al.
FRONTIERS IN IMMUNOLOGY (2020)
An Immunomodulatory Gallotanin-Rich Fraction From Caesalpinia spinosa Enhances the Therapeutic Effect of Anti-PD-L1 in Melanoma
Paola Lasso et al.
FRONTIERS IN IMMUNOLOGY (2020)
Targeting novel inhibitory receptors in cancer immunotherapy
Quan-Quan Ding et al.
SEMINARS IN IMMUNOLOGY (2020)
The therapeutic potential of resveratrol in a mouse model of melanoma lung metastasis
Amirhossein Davoodvandi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Oridonin inhibits 4T1 tumor growth by suppressing Treg differentiation via TGF-β receptor
Jufeng Guo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
PD-L1 degradation pathway and immunotherapy for cancer
Qian Gou et al.
CELL DEATH & DISEASE (2020)
Sulforaphane Promotes Dendritic Cell Stimulatory Capacity Through Modulation of Regulatory Molecules, JAK/STAT3-and MicroRNA-Signaling
Yangyi Wang et al.
FRONTIERS IN IMMUNOLOGY (2020)
An Overview of Cancer Prevention: Chemoprevention and Immunoprevention
Kyle J. Gu et al.
JOURNAL OF CANCER PREVENTION (2020)
Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma
Binghai Zhou et al.
THERANOSTICS (2020)
Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis
Peng Chen et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy
Cinzia Solinas et al.
ESMO OPEN (2020)
Fructose-1,6-bisphosphatase loss modulates STAT3-dependent expression of PD-L1 and cancer immunity
Bo Wang et al.
THERANOSTICS (2020)
Resveratrol exerts antitumor effects by downregulating CD8(+)CD122(+) Tregs in murine hepatocellular carcinoma
Qunfang Zhang et al.
ONCOIMMUNOLOGY (2020)
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
S. Trebeschi et al.
ANNALS OF ONCOLOGY (2019)
Lycopene improves the efficiency of anti-PD-1 therapy via activating IFN signaling of lung cancer cells
Xiufeng Jiang et al.
CANCER CELL INTERNATIONAL (2019)
Resveratrol antagonizes thyroid hormone-induced expression of checkpoint and proliferative genes in oral cancer cells
Chia-Cheng Lin et al.
JOURNAL OF DENTAL SCIENCES (2019)
Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma
Benjamin Bian et al.
ONCOIMMUNOLOGY (2019)
Triptolide and Its Derivatives as Cancer Therapies
Pawan Noel et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
Li-Chuan Chan et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Triptolide reverses helper T cell inhibition and down-regulates IFN- induced PD-L1 expression in glioma cell lines
Lei Zhang et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Progressive study of effects of erianin on anticancer activity
Yuying Zhang et al.
ONCOTARGETS AND THERAPY (2019)
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
Karine Flem-Karlsen et al.
SCIENTIFIC REPORTS (2019)
Icaritin promotes tumor T-cell infiltration and induces antitumor immunity in mice
Haibang Hao et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells
Wanfeng Gao et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Loss of Scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2/ROS and Nrf2/PD-L1 signaling
Na Wang et al.
EBIOMEDICINE (2019)
STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
Ioannis Zerdes et al.
CANCERS (2019)
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Shuang Qin et al.
MOLECULAR CANCER (2019)
Resveratrol induces immunogenic cell death of human and murine ovarian carcinoma cells
Yanke Zhang et al.
INFECTIOUS AGENTS AND CANCER (2019)
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Jun Wang et al.
CELL (2019)
Palmitoylation stabilizes PD-L1 to promote breast tumor growth
Yi Yang et al.
CELL RESEARCH (2019)
Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity
Kathleen M. Kokolus et al.
ONCOIMMUNOLOGY (2019)
Inflammation and Cancer
Nitin Singh et al.
ANNALS OF AFRICAN MEDICINE (2019)
Pembrolizumab for the treatment of nonsmall cell lung cancer: Current status and future directions
Qin Qin et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2019)
Curcumol: From Plant Roots to Cancer Roots
Wei Wei et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Curcumin converts Foxp3+regulatory T cells to T helper 1 cells in patients with lung cancer
Jian Y. Zou et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Curcumin enhances anti-tumor immune response in tongue squamous cell carcinoma
Feng Liao et al.
ARCHIVES OF ORAL BIOLOGY (2018)
Mechanisms of resistance to immune checkpoint inhibitors
Russell W. Jenkins et al.
BRITISH JOURNAL OF CANCER (2018)
Keaping a lid on lung cancer: the Keap1-Nrf2 pathway
Sarah A. Best et al.
CELL CYCLE (2018)
Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment
Sarah A. Best et al.
CELL METABOLISM (2018)
Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression
Jingjing Cong et al.
CELL METABOLISM (2018)
IDO1 in cancer: a Gemini of immune checkpoints
Lijie Zhai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammation
Wenwen Xu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
DAMP-TLR-cytokine axis dictates the fate of tumor
Ashok Patidar et al.
CYTOKINE (2018)
Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells
Yu Tang Chin et al.
ENDOCRINE-RELATED CANCER (2018)
Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells
Varun Sasidharan Nair et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Downregulation of BTLA on NKT Cells Promotes Tumor Immune Control in a Mouse Model of Mammary Carcinoma
Divya Sekar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Gut microbiome modulates efficacy of immune checkpoint inhibitors
Ming Yi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Ursolic acid in health and disease
Dae Yun Seo et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2018)
Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection
Jimin Xu et al.
MOLECULES (2018)
Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy
Bo Zhu et al.
ONCOGENE (2018)
Immunotherapy for Head and Neck Squamous Cell Carcinoma
Jessica Moskovitz et al.
CURRENT ONCOLOGY REPORTS (2018)
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
Jung-Mao Hsu et al.
NATURE COMMUNICATIONS (2018)
Pro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review
Gautam Sethi et al.
NUTRIENTS (2018)
PD-L1 expression is regulated by both DNA methylation and NF-kappa B during EMT signaling in non-small cell lung carcinoma
A. Asgarova et al.
ONCOIMMUNOLOGY (2018)
ICOS-L as a Potential Therapeutic Target for Cancer Immunotherapy
Oliviero Marinelli et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2018)
Emerging strategies for combination checkpoint modulators in cancer immunotherapy
Aleksandra Popovic et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
Jong-Ho Cha et al.
MOLECULAR CELL (2018)
Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth
Anchalee Rawangkan et al.
MOLECULES (2018)
Possible Mechanisms of Green Tea and Its Constituents against Cancer
Yohei Shirakami et al.
MOLECULES (2018)
Fraxinellone has anticancer activity in vivo by inhibiting programmed cell death-ligand 1 expression by reducing hypoxia-inducible factor-1α and STAT3
Yue Xing et al.
PHARMACOLOGICAL RESEARCH (2018)
The functional and inflammatory response of brain endothelial cells to Toll-Like Receptor agonists
Rebecca H. Johnson et al.
SCIENTIFIC REPORTS (2018)
The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
Xiaohong Cen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Not All Immune Checkpoints Are Created Equal
Annika De Sousa Linhares et al.
FRONTIERS IN IMMUNOLOGY (2018)
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors A Systematic Review and Meta-analysis
Daniel Y. Wang et al.
JAMA ONCOLOGY (2018)
The 2018 Nobel Prize in Physiology or Medicine: An exemplar of bench to bedside in immunology
Zuhair K. Ballas
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects
Lu Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota
Mengxue Dong et al.
CELL DEATH & DISEASE (2018)
Anti-breast Cancer Enhancement of a Polysaccharide From Spore of Ganoderma lucidum With Paclitaxel: Suppression on Tumor Metabolism With Gut Microbiota Reshaping
Jiyan Su et al.
FRONTIERS IN MICROBIOLOGY (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Resveratrol: A Double-Edged Sword in Health Benefits
Bahare Salehi et al.
BIOMEDICINES (2018)
Posttranslational Modifications of PD-L1 and Their Applications in Cancer Therapy
Jung-Mao Hsu et al.
CANCER RESEARCH (2018)
Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota
Jonathan M. Pitt et al.
ONCOIMMUNOLOGY (2017)
A comprehensive review on the anti-cancer properties and mechanisms of action of sesamin, a lignan in sesame seeds (Sesamum indicum)
Amin F. Majdalawieh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword
Marion Dajon et al.
IMMUNOBIOLOGY (2017)
The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3
Murali Janakiram et al.
IMMUNOLOGICAL REVIEWS (2017)
Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy
Robert J. Torphy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The Role of Resveratrol in Cancer Therapy
Jeong-Hyeon Ko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Toll-like receptor-4 signaling pathway in aorta aging and diseases: its double nature
Carmela Rita Balistreri et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans
J. Luis Espinoza et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells
Karine Flem-Karlsen et al.
PIGMENT CELL & MELANOMA RESEARCH (2017)
Increased BTLA and HVEM in gastric cancer are associated with progression and poor prognosis
Xiuwen Lan et al.
ONCOTARGETS AND THERAPY (2017)
β-Elemene: Mechanistic Studies on Cancer Cell Interaction and Its Chemosensitization Effect
Ziyu Jiang et al.
FRONTIERS IN PHARMACOLOGY (2017)
JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer
Chunwan Lu et al.
ONCOIMMUNOLOGY (2017)
Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer
Nadine Nelson et al.
PLOS ONE (2017)
Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane
Ravi Kumar et al.
PLOS ONE (2017)
Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune
Zhansheng Jiang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges
Xiangjiao Meng et al.
CANCER LETTERS (2017)
Synthesis and anti-tumor evaluation of panaxadiol halogen-derivatives
Shengnan Xiao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
Spencer C. Wei et al.
CELL (2017)
Targeting the TLR4 signaling pathway by polyphenols: A novel therapeutic strategy for neuroinflammation
Mahban Rahimifard et al.
AGEING RESEARCH REVIEWS (2017)
New Approaches in Glioblastoma Multiforme: The Potential Role of Immune-check Point Inhibitors
Francesca De Felice et al.
CURRENT CANCER DRUG TARGETS (2017)
Flavones: Food Sources, Bioavailability, Metabolism, and Bioactivity
Gregory L. Hostetler et al.
ADVANCES IN NUTRITION (2017)
Resveratrol inhibits lung cancer growth by suppressing M2-like polarization of tumor associated macrophages
Liwei Sun et al.
CELLULAR IMMUNOLOGY (2017)
Pharmacological effects of berberine and its derivatives: a patent update
Yifeng Jin et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1 alpha and STAT3
Jaemoon Koh et al.
ONCOIMMUNOLOGY (2016)
Silymarin suppressed lung cancer growth in mice via inhibiting myeloid-derived suppressor cells
Tiancong Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Antinociceptive Effects of Prim-O-Glucosylcimifugin in Inflammatory Nociception via Reducing Spinal COX-2
Liu-Qing Wu et al.
BIOMOLECULES & THERAPEUTICS (2016)
Deubiquitination and Stabilization of PD-L1 by CSN5
Seung-Oe Lim et al.
CANCER CELL (2016)
Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells
Melanie R. Power Coombs et al.
CANCER LETTERS (2016)
Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
Hidenari Hirata et al.
CANCER RESEARCH (2016)
Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities
K. M. Morrissey et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2016)
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation
Mingzhan Xue et al.
DIABETES (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt et al.
IMMUNITY (2016)
Sulforaphane regulates phenotypic and functional switching of both induced and spontaneously differentiating human monocytes
Sanjima Pal et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma
Yuta Kondo et al.
ORAL ONCOLOGY (2016)
B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway
Bo Jiang et al.
TUMOR BIOLOGY (2016)
Immune-system-dependent anti-tumor activity of a plant-derived polyphenol rich fraction in a melanoma mouse model
A. Gomez-Cadena et al.
CELL DEATH & DISEASE (2016)
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Chia-Wei Li et al.
NATURE COMMUNICATIONS (2016)
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Shohei Koyama et al.
NATURE COMMUNICATIONS (2016)
Tumor microenvironment: Sanctuary of the devil
Lanlan Hui et al.
CANCER LETTERS (2015)
Multifunctional T Lymphocytes Generated After Therapy With an Antitumor Gallotanin-Rich Normalized Fraction Are Related to Primary Tumor Size Reduction in a Breast Cancer Model
Claudia Uruena et al.
INTEGRATIVE CANCER THERAPIES (2015)
Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases
Ali Roohbakhsh et al.
LIFE SCIENCES (2015)
On the antioxidant, neuroprotective and anti-inflammatory properties of S-allyl cysteine: An update
Ana Laura Colin-Gonzalez et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, 0X40, GITR, CD27, CD28, and ICOS
Miguel F. Sanmamed et al.
SEMINARS IN ONCOLOGY (2015)
Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
Theodore Kouo et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
Francesca De Felice et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Beyond CTLA-4 and PD-1, the generation Z of negative checkpoint regulators
Isabelle Le Mercier et al.
FRONTIERS IN IMMUNOLOGY (2015)
S-allylcysteine, a garlic derivative, suppresses proliferation and induces apoptosis in human ovarian cancer cells in vitro
Ya-si Xu et al.
ACTA PHARMACOLOGICA SINICA (2014)
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function
Robert J. Johnston et al.
CANCER CELL (2014)
TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells
Hongliang Fang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2014)
Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
Xiaozhou Fan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Fructose-1,6-bisphosphatase opposes renal carcinoma progression
Bo Li et al.
NATURE (2014)
VISTA Is a Novel Broad-Spectrum Negative Checkpoint Regulator for Cancer Immunotherapy
J. Louise Lines et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer
Chenfang Dong et al.
CANCER CELL (2013)
Elemene, One Ingredient of a Chinese Herb, Against Malignant Tumors: A Literature-based Meta-analysis
Hong-Bin Xu et al.
CANCER INVESTIGATION (2013)
Covalent lipid modifications of proteins
Marilyn D. Resh
CURRENT BIOLOGY (2013)
From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer
Helen Angel et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Toll-Like Receptor 4 Activity Protects Against Hepatocellular Tumorigenesis and Progression by Regulating Expression of DNA Repair Protein Ku70 in Mice
Ziyan Wang et al.
HEPATOLOGY (2013)
REGULATORY T-CELL MODULATION BY GREEN TEA IN CHRONIC LYMPHOCYTIC LEUKEMIA
G. D'Arena et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2013)
Therapeutic Potential of B and T Lymphocyte Attenuator Expressed on CD8+ T Cells for Contact Hypersensitivity
Daiki Nakagomi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Polydatin: A review of pharmacology and pharmacokinetics
Qiao-Hui Du et al.
PHARMACEUTICAL BIOLOGY (2013)
B7 family checkpoint regulators in immune regulation and disease
Sabrina Ceeraz et al.
TRENDS IN IMMUNOLOGY (2013)
Ganoderma lucidum Extract Induces G1 Cell Cycle Arrest, and Apoptosis in Human Breast Cancer Cells
Guosheng Wu et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2012)
Silibinin – A Promising New Treatment for Cancer
Catherine Wing Ying Cheung et al.
Anti-Cancer Agents in Medicinal Chemistry (2012)
Natural Products: Promising Resources for Cancer Drug Discovery
Susmita Mondal et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
Berberine: New perspectives for old remedies
Micol Tillhon et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Seng-Ryong Woo et al.
CANCER RESEARCH (2012)
Tim-3, a negative regulator of anti-tumor immunity
Ana Carrizosa Anderson
CURRENT OPINION IN IMMUNOLOGY (2012)
Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
Tadashi Yokosuka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
Xin Gao et al.
PLOS ONE (2012)
Ginsenosides as anticancer agents: in vitro and in vivo activities, structure-activity relationships, and molecular mechanisms of action
Subhasree Ashok Nag et al.
FRONTIERS IN PHARMACOLOGY (2012)
Crosstalk between T Lymphocytes and Dendritic Cells
Claire Hivroz et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers
Christine Morand et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2011)
Plant homologue constitutive photomorphogenesis 9 (COP9) signalosome subunit CSN5 regulates innate immune responses in macrophages
Zhongbin Deng et al.
BLOOD (2011)
Prospects for TIM3-Targeted Antitumor Immunotherapy
Shin Foong Ngiow et al.
CANCER RESEARCH (2011)
Anti-TIM3 Antibody Promotes T Cell IFN-γ-Mediated Antitumor Immunity and Suppresses Established Tumors
Shin Foong Ngiow et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
PD-L1 expression on tolerogenic APCs is controlled by STAT-3
Sabine J. Woelfle et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation
Marcos W. Steinberg et al.
IMMUNOLOGICAL REVIEWS (2011)
Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity
Feifei Luo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation
Hao Liu et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The Accumulation and Prognosis Value of Tumor Infiltrating IL-17 Producing Cells in Esophageal Squamous Cell Carcinoma
Lin Lv et al.
PLOS ONE (2011)
Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker
Max Jan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Slow Down and Survive: Enigmatic Immunoregulation by BTLA and HVEM
Theresa L. Murphy et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
ERK/p38 MAP-kinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets
Svetlana Karakhanova et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
TLRs and chronic inflammation
Caroline Ospelt et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Putting the brakes on BTLA in T cell-mediated cancer immunotherapy
Chrystal M. Paulos et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion
Huan Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion
Xiaoyuan Huang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Kaori Sakuishi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Apigenin: A Promising Molecule for Cancer Prevention
Sanjeev Shukla et al.
PHARMACEUTICAL RESEARCH (2010)
High Expression of the Inhibitory Receptor BTLA in T-Follicular Helper Cells and in B-Cell Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia
Hasni M'Hidi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
COP9-Associated CSN5 Regulates Exosomal Protein Deubiquitination and Sorting
Yuelong Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Sulforaphane Inhibits Prostate Carcinogenesis and Pulmonary Metastasis in TRAMP Mice in Association with Increased Cytotoxicity of Natural Killer Cells
Shivendra V. Singh et al.
CANCER RESEARCH (2009)
B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma
Ryo Yamamoto et al.
CANCER SCIENCE (2009)
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Trine H. Mogensen
CLINICAL MICROBIOLOGY REVIEWS (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Distribution and Biological Activities of the Flavonoid Luteolin
Miguel Lopez-Lazaro
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Pentacyclic Triterpene Distribution in Various Plants - Rich Sources for a New Group of Multi-Potent Plant Extracts
Sebastian Jaeger et al.
MOLECULES (2009)
PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer
C. A. Crane et al.
ONCOGENE (2009)
Triptolide inhibits interferon-γ-induced programmed death-1-ligand 1 surface expression in breast cancer cells
Mei Liang et al.
CANCER LETTERS (2008)
Multitargeted therapy of cancer by silymarin
Kumaraguruparan Ramasamy et al.
CANCER LETTERS (2008)
TLR4 signaling promotes the expression of VEGF and TGF beta(1) in human prostate epithelial PC3 cells induced by lipopolysaccharide
Zengyang Pei et al.
CELLULAR IMMUNOLOGY (2008)
The role of TLR activation in inflammation
I. Sabroe et al.
JOURNAL OF PATHOLOGY (2008)
Anti-carcinogenic Effects of the Flavonoid Luteolin
Guenter Seelinger et al.
MOLECULES (2008)
CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator
Guifang Cai et al.
NATURE IMMUNOLOGY (2008)
A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials
Yao-Zu Xiang et al.
PHYTOTHERAPY RESEARCH (2008)
Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
Mohsen Imanshahidi et al.
PHYTOTHERAPY RESEARCH (2008)
Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
Michal Marzec et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Combined coinhibitory and costimulatory modulation with Anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts
W. Truong et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival
Wayne Truong et al.
TRANSPLANTATION (2007)
Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-γ and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway
Jizhong Liu et al.
BLOOD (2007)
A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells
Xin Huang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Antiproliferative prenylated stilbenes and flavonoids from Macaranga alnifolia from the Madagascar rainforest
Brent J. Yoder et al.
JOURNAL OF NATURAL PRODUCTS (2007)
Silybin and silymarin - New and emerging applications in medicine
Radek Gazak et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Bioactive constituents of Spatholobus suberectus in regulating tyrosinase-related proteins and mRNA in HEMn cells
Mei-Hsien Lee et al.
PHYTOCHEMISTRY (2006)
TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer
MG Kelly et al.
CANCER RESEARCH (2006)
Beneficial effects of green tea -: A review
C Cabrera et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2006)
Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-γ-induced upregulation of B7-H1 (CD274)
SJ Lee et al.
FEBS LETTERS (2006)
CD8(+) T-cell memory in tumor immunology and immunotherapy
Christopher A. Klebanoff et al.
IMMUNOLOGICAL REVIEWS (2006)
Balancing co-stimulation and inhibition with BTLA and HVEM
Kenneth M. Murphy et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells
M Kisielow et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator
JR Sedy et al.
NATURE IMMUNOLOGY (2005)
Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells
Y Fu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Murine B7-H3 is a negative regulator of T cells
DVR Prasad et al.
JOURNAL OF IMMUNOLOGY (2004)
Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate for proteasomal degradation of Nrf2
A Kobayashi et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex
DD Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
TH Wang et al.
NATURE MEDICINE (2004)
An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection
P Han et al.
JOURNAL OF IMMUNOLOGY (2004)
Pharmacological effects of green tea on the gastrointestinal system
MWL Koo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Toll-like receptor signaling
S Akira
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses
WK Suh et al.
NATURE IMMUNOLOGY (2003)
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
N Watanabe et al.
NATURE IMMUNOLOGY (2003)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
CTLA-4: new insights into its biological function and use in tumor immunotherapy
JG Egen et al.
NATURE IMMUNOLOGY (2002)
Plant foods and herbal sources of resveratrol
J Burns et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2002)
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
L Monney et al.
NATURE (2002)
Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength
JG Egen et al.
IMMUNITY (2002)
Chemistry and pharmacology of the Citrus bioflavonoid hesperidin
A Garg et al.
PHYTOTHERAPY RESEARCH (2001)
Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium Wilfordii Hook F
BJ Chen
LEUKEMIA & LYMPHOMA (2001)
Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants
KH Miean et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2001)
B7-H3:: A costimulatory molecule for T cell activation and IFN-γ production
AI Chapoval et al.
NATURE IMMUNOLOGY (2001)
Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile
M Churchill et al.
JOURNAL OF SURGICAL RESEARCH (2000)
Share Paper
